Clinical Trial Update: Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating thalidomide with temozolomide or with Camptothecin-11 (irinotecan) in gliomas has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme
• Glioma

Drugs mentioned

• Irinotecan (Irinotecan)
• Temozolomide (Temozolomide)
• Thalidomide (thalidomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Glioblastoma Multiforme, Glioma | Phase 2 | Status: COMPLETED | Results posted: 2012-02-28